Category: CD as API
HPαCD More Effective than HPβCD Against Breast Cancer
Wittkowski et al. recently published their results on re-evaluation of three genome-wide association studies using computational biostatistics approach. The genetic
First cannabidiol product approved by FDA as medication
Cannabis has been used for medicinal purposes for thousands of years. Its active compounds produce pharmacological effects throughout the body,
HPBCD can cross the Brain-Blood Barrier
Matencio et al. reported in their recent paper that 92.8% of HPBCD administered intrathecally to a child suffering from Niemann
Annual National Niemann Pick Disease Foundation Conference
Among several lectures useful for the families with member(s) suffering in rare diseases the ongoing clinical trials for NPC patients